Editorial Staff

Amar Sawhney on Sikhs, STEM & COVID

/in , , , , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

The entrepreneurial spirit among immigrants and refugees allows them the flexibility to pursue unexpected courses of action, adapt, accept risk and make the most of opportunities they didn’t even know of before. For Dr. Amar Sawhney from India, that started at the University of Texas at Austin with 30 job rejections out of 30 applications. But he charted a path that would see him go in directions hitherto unknown to him: getting a PhD, helping found a company, journeying to Boston, and starting a string of new companies, using his chemical engineering background to save lives through remarkable local therapy innovations. To date, he has founded eight companies accounting for 4,000 jobs and more than $2 billion in revenue. He’s been named a “Champion of Change” by The White House, one of the “five most innovative Medical Device CEOs” by MassDevice, the EY regional entrepreneur of the year, The Immigrant Learning Center’s own Immigrant Entrepreneur Awardee for Life Science Business. But his influence extends well beyond that space into environmental conservationism, safeguarding refugees, mentoring and promoting STEM education, and building public understanding of America’s Sikhs, as you’ll hear in this week’s episode of JobMakers.

Guest:

Amarpreet Sawhney, Ph.D., is the Chairman and CEO OF Instylla Inc which is developing new liquid embolics for tumor embolization and hemostasis. He is also CEO of Rejoni Inc., which is developing products to prevent adhesions following gynecological interventions. Previously he was President and CEO of Ocular Therapeutix, Inc. (OCUL: NASDAQ) a company focused on unmet needs in ophthalmic drug delivery. He was also the Chairman of Augmenix, Inc. (acquired by Boston Scientific), Founder and CEO of Confluent Surgical (acquired by Covidien), the Chairman of MarketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence, technology founder of Focal, Inc. (acquired by Genzyme) and Access Closure Inc. (acquired by Cardinal Health). He holds over 120 patents, which form the basis for several first-of-a-kind medical devices that have helped over 5 million patients worldwide. He has founded eight companies, which account for over 4,000 jobs created and over $2 billion in revenue to date. Dr. Sawhney helps foster entrepreneurship by mentoring young innovators and creating companies through Incept, a medical device incubator. He is a member of the board of directors of EcoSikh, Axtria, Imperative care, Instylla, Rejoni, Tulavi, and Incept LLC. He is on the advisory board of the MIT museum. Dr. Sawhney is passionate about education, wildlife, and environmental causes, which he is involved in supporting through his family foundation. Dr. Sawhney has been recognized by several awards including being named the “Champions of Change” and “Outstanding American by Choice” awards by the Whitehouse, “Five most innovative Medical Device CEOs” by MassDevice, MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, the E&Y regional entrepreneur of the year award, Mass High Tech All Star award, TiE Star award, the University of Texas Outstanding Young Engineering Graduate award, and the Indian Institute of Technology Delhi Distinguished Alumni award. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi.

Get new episodes of JobMakers in your inbox!

Browse recent episodes of Pioneer podcasts:

Realizing Rent Control: Targeted Tenant Relief or Broad-Based Road to Ruin

0 Comments
/
Joe Selvaggi talks with Greater Boston Real Estate Board’s President and CEO Greg Vasil about the likely effect on all residents of Boston of Mayor Wu's rent control proposal now before the City Council.

India Unbound: Gurcharan Das on the Rise of the World’s Largest Free-Market Democracy

0 Comments
/
This week on The Learning Curve, Gurcharan Das, author, public intellectual, and former CEO of Procter & Gamble India, discusses the rise of India since independence to become a thriving, incredibly diverse nation of 1.4 billion people—the world's largest free-market democracy.

Unchecked Agency Power: Consumer Safety Bans Fair Process

0 Comments
/
Joe Selvaggi talks with Pacific Legal Foundation senior attorney Oliver Dunford about his work on Leachco v. Consumer Product Safety Commission, a case challenging the constitutionality of an executive agency structure (CPSC), in which leadership is beyond presidential removal, which uses its product safety mandate to ban products with no independent recourse for producers.

Dr. Deborah Plant on Zora Neale Hurston’s Barracoon: The Story of the Last “Black Cargo”

0 Comments
/
This week on The Learning Curve, Dr. Deborah Plant, editor of the 2018 book Barracoon: The Story of the Last “Black Cargo" discusses Zora Neale Hurston's work as an anthropologist telling the story of one of the last survivors of the infamous Middle Passage.

Cooking Without Gas: Stove Ban a Plan or Conspiracy Theory

0 Comments
/
Joe Selvaggi talks with reporter and author of six climate policy books Robert Bryce about his investigation into the statements made by the U.S. Consumer Product Safety Commissioner about the safety of gas cooking and the origins of the movement that assert that such appliances could be and should be banned.

George Weigel Discusses Pope St. John Paul II for National Catholic Schools Week

0 Comments
/
This week on The Learning Curve, George Weigel, the biographer of Pope St. John Paul II explores how Karol Wojtyla's education, deep faith, and experiences during World War II shaped his life as a spiritual leader and helped lead to the fall of Communism.

Innovation Reduction Act: Price Controls’ Prescription for New Therapies

0 Comments
/
Joe Selvaggi talks with Pioneer Institute’s senior fellow Dr. Bill Smith about the changes to drug pricing laws included in the recently passed Inflation Reduction Act provisions and discuss who wins and loses as drug companies announce their response to new law.

Award-Winning UK Author & Filmmaker Laurence Rees on the Holocaust, Auschwitz, and Remembrance

0 Comments
/
To mark International Holocaust Remembrance Day, Laurence Rees, a former head of BBC TV History Programmes and author of The Holocaust: A New History, sheds light on Germany in the 1920s and 1930s and the cultural and political conditions that led to the Holocaust.

D.C.’s Kevin Chavous on National School Choice Week

0 Comments
/
This week on The Learning Curve, Cara and Gerard talk with Kevin Chavous, president of Stride K12, Inc. and a former member of the Council of the District of Columbia, on the growing movement toward school choice in education. Chavous discusses recent Supreme Court rulings and the expansion of school choice programs, education savings accounts, and vouchers.

Residents Rescuing Refugees: Welcoming Ukrainians Yearning To Breathe Free

0 Comments
/
Host Joe Selvaggi talks with George Mason Law Professor, author, and immigration expert Ilya Somin about the newly announced Welcome Corps program which empowers Americans to sponsor and help relocate refugees from Ukraine and other places of war and persecution.

Pulitzer Winner Prof. David Garrow on the Rev. Dr. Martin Luther King, Jr. and the Civil Rights Movement

0 Comments
/
https://chrt.fm/track/4655F8/api.spreaker.com/download/episode/53284998/tlc_davidgarrow.mp3 This…

Sinking U.S. Shipping: Ineffective Law Creates Waves for American Economy

Host Joe Selvaggi talks with Cato Institute research fellow Colin Grabow about the failure of the Jones Act, a law that sought to protect the U.S. shipbuilding and merchant marine capacity. They examine its downstream effects on inflation, supply chain fragility, and energy access that directly affect every American.